Floatz logo

61 assets in Bipolar Disorder

Therapeutic assets addressing Bipolar Disorder, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Dulaglutide
Bipolar Disorder
First Affiliated Hospital of Zhejiang UniversityN/AD (30)
Empagliflozin
Bipolar Disorder
University of Sao PauloN/AD (30)
Flumazenil
Bipolar Disorder
Anders JørgensenN/AD (30)
.Gamma.-Cyclodextrin, 6A,6B,6C,6D,6E,7F,6G,6H-Octakis-S-(2-Carboxyethyl)-6A,6B,6C,6D,6E,7F,6G,6H-Octathio-
Bipolar Disorder
Medipol UniversityN/AD (30)
Maltodextrin
Bipolar Disorder
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)N/AD (30)
Nicotine
Bipolar Disorder
Wake Forest University Health SciencesN/AD (30)
Semaglutide
Bipolar Disorder
Ludwig-Maximilians - University of MunichN/AD (30)
Sodium Alginate
Bipolar Disorder
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)N/AD (30)
Abbv-932
Bipolar Disorder
AbbVieP2NR ()
Alto-100
Bipolar Disorder
Alto NeuroscienceP2NR ()
Showing 51 to 61 of 61 assets
PreviousPage 2 of 2Next